格列奈类药物 structure

格列奈类药物

TL;DR: 格列奈类药物 (CAS 54870-28-9) is a chemical compound with molecular formula C17H16ClNO4 and molecular weight 333.08 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.

格列奈类药物

4-[2-[(5-chloro-2-methoxybenzoyl)amino]ethyl]benzoic acid

Also Known As: Meglitinide, Meglitinidum, meglitinida, Meglitinido, Meglitinide [INN]

CAS: 54870-28-9
Molecular Formula C17H16ClNO4
Molecular Weight 333.08 g/mol
LogP 3.4
Topological Polar Surface Area 75.6 Ų
Hydrogen Bond Donors 2
Hydrogen Bond Acceptors 4
Rotatable Bonds 6
Exact Mass 333.07678
Heavy Atoms 23
Complexity 409.0

Chemical Identifiers

CAS Number 54870-28-9
SMILES COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)C(=O)O
InChIKey SWLAMJPTOQZTAE-UHFFFAOYSA-N

Patent-Derived Application Labels

Derived from 8 IPC patent classification(s) across the SureChEMBL global patent database.

Agrochemicals (30 patents) Analytical Reagents (19 patents) Biotechnology (38 patents) Heterocyclic Building Blocks (2220 patents) Organic Building Blocks (383 patents) +3 more

Product Overview

格列奈类药物 (CAS 54870-28-9), with molecular formula C17H16ClNO4 and molecular weight 333.08 g/mol. IUPAC: 4-[2-[(5-chloro-2-methoxybenzoyl)amino]ethyl]benzoic acid.

🧪
Safety Data Sheet (MSDS / SDS) View the Laboratory Chemical Safety Summary (LCSS) on PubChem — includes GHS classifications, hazard statements, first aid measures, and handling precautions.
View MSDS →

Chemical Property Profile of 格列奈类药物

XLogP
3.4
TPSA (Topological Polar Surface Area)
75.6
Hydrogen Bond Donors
2
Hydrogen Bond Acceptors
4
Rotatable Bonds
6
Heavy Atoms
23
Complexity
409.0
Exact Mass
333.07678
Monoisotopic Mass
333.07678
Data Source: Chemical property values are referenced from PubChem, the world's largest open chemistry database maintained by the National Center for Biotechnology Information (NCBI), U.S. National Library of Medicine.

Property Insights of 格列奈类药物

The XLogP value of 3.4 indicates that 格列奈类药物 is lipophilic (fat-soluble), which may influence its absorption, distribution, and formulation strategy. The TPSA of 75.6 Ų falls within the moderate polarity range, balancing permeability and solubility for 格列奈类药物. Following Lipinski's Rule of Five, 格列奈类药物 has 2 hydrogen bond donor(s) and 4 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.

Frequently Asked Questions

What is the typical lead time for this product?
Lead time typically ranges from 3-7 business days for in-stock items. For larger quantities or custom orders, please contact us for specific lead times.
Can you provide samples for testing?
Yes, we offer sample quantities for quality testing. Please submit an inquiry with your requirements and we will arrange samples accordingly.
What documentation do you provide with the product?
We provide COA (Certificate of Analysis), MSDS (Material Safety Data Sheet), and technical data sheets with each shipment.
Do you ship internationally?
Yes, we ship to most countries worldwide. Shipping costs and delivery times vary by location. Please contact us for specific shipping information.

Frequently Asked Questions

What is the CAS number of 格列奈类药物?

The CAS number of 格列奈类药物 is 54870-28-9.

What is the molecular formula of 格列奈类药物?

The molecular formula of 格列奈类药物 is C17H16ClNO4.

What is the molecular weight of 格列奈类药物?

The molecular weight of 格列奈类药物 is 333.08 g/mol.

Where can I buy 格列奈类药物?

You can request a quote for 格列奈类药物 directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.

Does KEHONG BIO offer custom synthesis for 格列奈类药物?

Yes, KEHONG BIO provides custom synthesis services for 格列奈类药物 and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.

🤖 科弘生物 AI 助手 ×
您好!我是 科弘生物 AI 助手。可以问我产品搜索、询价、样品或技术问题。如何帮助您?